外泌体诊断和治疗市场基于(主要区域、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00005514
  • Category : Biotechnology
  • Status : Data Released
  • No. of Pages : 150
Buy Now

外泌体诊断和治疗市场预计2021年为7603万美元,2023年为20亿美元。预计到2031年将达到15.4245亿美元,到2031年复合年增长率为35.1%。外泌体研究不断取得进展和技术、改进的分离技术以及增强治疗应用的外泌体工程可能仍然是外泌体诊断和治疗市场的关键趋势。

 

外泌体诊断和治疗市场分析

慢性病患病率的不断上升预计将推动外泌体诊断和治疗市场的增长。外泌体参与癌症、妊娠疾病、神经退行性疾病和心血管疾病等疾病的发病机制,是用于诊断、预后和治疗多种疾病的潜在非侵入性生物标志物。根据欧盟委员会的数据,欧盟成员国新增癌症病例 274 万例。

 

外泌体诊断和治疗市场概述

全球外泌体诊断和治疗市场按地区划分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。由于对新型诊断疗法的需求不断增加、整体医疗保健基础设施的发展以及人们对基于外泌体的诊断所带来的好处的认识不断提高等因素,预计该地区的市场将增长。然而,专业知识的缺乏可能会在一定程度上限制市场的增长。

 

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

外泌体诊断和治疗市场:

外泌体诊断和治疗市场

  • 年均复合增长率(2023 - 2031)
    35.1%
  • 2021年市场规模
    7603万美元
  • 2031年市场规模
    15.4245亿美元

市场动态

增长动力
  • 外泌体研究和开发活动的增加
未来的趋势
  • 外泌体分离过程的自动化
机会
  • 对非侵入性和新型诊断程序的偏好日益增长

关键人物;主力;重要一员

  • Aethlon 医疗公司,
  • 治疗解决方案国际公司
  • ReNeuron 集团有限公司,
  • 免疫治疗控股公司,
  • 细胞引导系统有限责任公司,
  • 生物再生科学,
  • Evomic 科学有限责任公司,
  • 诺根生物技术公司,
  • 外泌体诊断公司
  • 生物技术,

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

产品
  • 诊断
  • 治疗性
服务
  • 乐器
  • 试剂
  • 软件
最终用户
  • 癌症研究所
  • 医院
  • 诊断中心
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

外泌体诊断和治疗市场驱动因素和机遇

 

研究和开发活动的增加可能有利于市场。

一些市场参与者和医疗保健组织正在实施战略以促进外泌体应用的研发活动。例如,哥伦比亚巴兰基亚北方大学医学系进行了一项关于“外泌体:潜在疾病生物标志物和新治疗靶点”的研究。该研究提出了外泌体在未来临床实践中使用的观点。

由于这些因素,外泌体诊断和治疗变得越来越重要。

 

对非侵入性和新型诊断程序的日益青睐——外泌体诊断和治疗市场的机遇

外泌体通过在外泌体产生细胞和靶细胞之间交换脂质和蛋白质来促进细胞间通讯。此外,它们还通过细胞及其微环境之间生物分子的水平转移实现细胞内通讯。正在进行的研究表明,外泌体在心血管、免疫和神经疾病的诊断以及癌症等慢性疾病的发病机制中发挥着重要的生理作用。大量初创公司正在进入市场,旨在满足新型侵入性诊断程序的需求。例如,2015年,一群研究人员成立了一家新公司Exocan,主要目标是开发基于外泌体的诊断平台,借助尿液和唾液准确、无创地诊断癌症。

 

外泌体诊断和治疗市场报告细分分析

有助于外泌体诊断和治疗市场分析推导的关键部分是服务和应用。

  • 根据应用,外泌体诊断和治疗市场分为诊断应用和治疗应用。 2023年,诊断应用领域占据最大市场份额。此外,治疗应用领域预计在预测期内将以最快的速度增长。
  • 按产品划分,外泌体诊断和治疗市场分为仪器、试剂和软件。仪器细分市场在 2019 年占据最大市场份额,软件细分市场预计在预测期内将实现最高的复合年增长率。
  • 外泌体诊断和治疗市场已按最终用户细分为癌症研究所、医院、诊断中心等。 2023 年,癌症研究所细分市场在最终用户中占据最大市场份额。此外,预计同一细分市场在预测期内增长最快。

 

按地域划分的外泌体诊断和治疗市场份额分析

外泌体诊断和治疗市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美洲/中南美洲。

北美洲包括美国、加拿大和墨西哥。北美在外泌体诊断和治疗市场中占据最大份额,其中美国占据最大市场份额,其次是加拿大。美国在外泌体诊断和治疗市场中占有最大份额,这归因于使用外泌体作为癌症诊断生物标志物的需求增加,以及癌症患病率的增加、人口老龄化和生活方式的改变。此外,强大的产品线、主要参与者的存在以及完善的监管政策预计将在预测期内推动北美外泌体诊断和治疗市场的发展。

亚太地区预计将成为所有其他地区中增长最快的地区。由于有利的监管环境、对优质治疗解决方案的需求不断增加以及对外泌体研发活动的日益关注等因素,预计亚太地区的市场增长将以更快的速度增长。此外,扩大医疗基础设施和增加投资以促进研究活动预计将在预测期内推动亚太地区外泌体诊断和治疗市场的发展。

 

外泌体诊断和治疗市场报告范围

报告属性细节
2021年市场规模7603万美元
2031 年市场规模15.4245亿美元
全球复合年增长率(2023 - 2031)35.1%
历史数据2021-2022
预测期2024-2031
涵盖的细分市场按产品分类
  • 诊断
  • 治疗性
按服务
  • 乐器
  • 试剂
  • 软件
按最终用户
  • 癌症研究所
  • 医院
  • 诊断中心
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • Aethlon 医疗公司,
  • 治疗解决方案国际公司
  • ReNeuron 集团有限公司,
  • 免疫治疗控股公司,
  • 细胞引导系统有限责任公司,
  • 生物再生科学,
  • Evomic 科学有限责任公司,
  • 诺根生物技术公司,
  • 外泌体诊断公司
  • 生物技术,
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

外泌体诊断和治疗市场新闻和最新动态

外泌体诊断和治疗市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。以下是外泌体诊断和治疗策略市场的进展列表:

  • 2023 年 7 月,总部位于德克萨斯州的 Direct Biologics 宣布了一项 II 期试验的可喜结果,显示其外泌体 ExoFlo 降低了患有急性呼吸窘迫综合征的长期新冠患者的死亡率。 (来源:公司新闻稿)
  • 2024年1月,比利时生物技术公司EXO Biologics SA推出了ExoXpert,这是一家专门从事外泌体开发的合同开发和制造组织(CDMO),该公司利用外泌体开发生物制药来治疗罕见疾病。 (来源:公司新闻稿)

 

外泌体诊断和治疗市场报告范围和交付成果

《外泌体诊断和治疗市场规模及预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

  • 范围内涵盖的所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,例如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析,涵盖主要市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports